Jefferies Raises Price Target on DexCom (DXCM) 40% After Q4 Results

Jefferies boosted its price target DexCom (NASDAQ: DXCM) from $10 to $14 and reiterated its Buy rating following Q4 results.

The firm comments, "DXCM preannounced 4Q results of $22.4mn, reflecting a strong seasonal uptick in sensor utilization. 2012 is shaping up to be a year of investment as the company sets the stage for the Gen4 sensor launch."

FY12 EPS was trimmed from ($0.57) to ($0.72).

For an analyst ratings summary and ratings history on DexCom click here. For more ratings news on DexCom click here.

Shares of DexCom closed at $11.19 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Keurig Dr Pepper (KDP) PT Raised to $39 at Jefferies
• Meta Platforms Inc. (META) PT Lowered to $575 at UBS, 'shares are offering a 3-to-1 skew'
• META to capture largest share of users, SNAP to benefit from ad budget shifts - Canaccord Genuity weighs in on TikTok ban